Hormone therapy safe for women, study finds

Hormone therapy safe for women
The study showed treatment using a combination of hormones estradiol and drospirenone resulted in significant improvement in menopausal symptoms.

(Medical Xpress)—A new study has examined the cognitive effects of hormone therapy on memory, language and concentration in menopausal women.

A study, published in the Menopause journal, examined the effects of (HRT) E2D, which used a combination of hormones estradiol and drospirenone to treat women. Early postmenopausal women aged between 49 and 55 who had never used HRT were assessed over a six-month period.

The treatment resulted in significant improvement in menopausal symptoms including hot flushes, night sweats, and sexual function, and it lowered blood pressure and weight in comparison to those who were treated with an identical placebo.

The women also underwent cognitive assessment and were asked to perform during a brain-imaging (MRI) scan.

Estradiol, a form of oestrogen combined with drospirenone, a progestin, were found to have no effect on the of early postmenopausal women.

Professor Susan Davis, Director of the Women's Health Research Program in the Monash University School of Public Health and Preventive Medicine, said there had long been debate about the safety of hormone replacement therapies and the potential adverse effects on cognitive function in women.

"These findings are reassuring for women," Professor Davis said.

"We report, for the first time, that combined with estradiol has no overall effect on the cognitive performance of postmenopausal women examined over a 26-week period.

"Although hormone replacement therapy is no quick fix to the challenge of menopause, it does show that the E2D treatment can be useful in the overall management of menopause, and without adversely effecting cognitive ability."

Professor Davis said memory and mood complaints were frequent in women after menopause due to oestrogen deficiency, including a lack of clarity of thought and memory or word-finding difficulties.

add to favorites email to friend print save as pdf

Related Stories

Testosterone therapy improves memory in postmenopausal women

Jun 06, 2011

Post-menopausal women have better memory after daily treatment with a testosterone spray for six months, a new preliminary study finds. The results will be presented Saturday at The Endocrine Society's 93rd Annual Meeting ...

Recommended for you

FDA OKs Cubist antibiotic for serious infections

9 hours ago

The Food and Drug Administration has approved a new medicine to fight complex infections in the abdomen and urinary tract, the fourth antibiotic the agency has approved since May.

Xtoro approved for swimmer's ear

Dec 18, 2014

(HealthDay)—Xtoro (finafloxacin otic suspension) eardrops have been approved by the U.S. Food and Drug Administration to treat swimmer's ear, clinically known as acute otitis externa.

Drug interaction identified for ondansetron, tramadol

Dec 18, 2014

(HealthDay)—In the early postoperative period, ondansetron is associated with increased requirements for tramadol consumption, according to a review and meta-analysis published online Dec. 10 in Anaesthesia.

New system targets germs in donated blood plasma

Dec 17, 2014

(HealthDay)—A new system designed to eliminate germs in donated blood plasma and reduce the risk of transmitting a plasma-borne infection has been approved by the U.S. Food and Drug Administration.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.